USPTO serial 79344236
ABINVIVO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 5, 2024
- Examiner
- CORDOVA, RAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ABINVIVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth P. West
Elizabeth P. West Bay State IP, LLC10 Post Office Square, Suite 800 SouthBoston, MA 02109UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for scientific and medical research; enzymes for industrial purposes; industrial chemicals; cultures of microorganisms, other than for medical and veterinary use; diagnostic preparations, other than for medical or veterinary purposes; stem cells, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical catalysts; proteins for the food industry | ACTIVE | — |
| 005 | Vaccines; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; living cells for medical purposes; diagnostic biomarker reagents for medical purposes; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use | ACTIVE | — |
| 042 | Research and development services in the field of antibodies; pharmaceutical research and development; research and development of new products for others; biological research; medical research laboratory services; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; structural and functional analysis of genomes; genetic testing for scientific research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biointron Biological Inc.
- Other trademarks owned by Biointron Biological Inc.
- Other trademarks owned by Biointron Biological Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ABINVIVO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 2, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 18, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 30, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |